Live Breaking News & Updates on Institutional Investors Weigh In On Amneal Pharmaceuticals

Stay updated with breaking news from Institutional investors weigh in on amneal pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 6.4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report)’s stock price shot up 6.4% on Tuesday . The company traded as high as $6.90 and last traded at $6.86. 685,390 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 1,502,379 shares. The stock had previously closed at $6.45. Analysts […] ....

Piper Sandler , Sherbrooke Park Advisers , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals , Atlanta Consulting Group Advisors , Amneal Pharmaceuticals Company Profile , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Stock Performance , Goldman Sachs Group , Institutional Investors Weigh In On Amneal Pharmaceuticals , Get Free Report , Capital Management , Park Advisers , Consulting Group Advisors , Bayesian Capital Management , Amneal Pharmaceuticals Daily ,

Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) PT at $7.31

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been given an average recommendation of “Buy” by the four research firms that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have covered the […] ....

United States , Piper Sandler , Amneal Pharmaceuticals Inc , Goldman Sachs Group , Institutional Investors Weigh In On Amneal Pharmaceuticals , Amneal Pharmaceuticals , Connor Clark Lunn Investment Management Ltd , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Stock Performance , Caxton Associates , Get Free Report , Marketbeat Ratings , Investment Management , Lunn Investment Management , Public Employees Retirement System , Get Free , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shot up 1.9% on Wednesday . The company traded as high as $5.86 and last traded at $5.84. 420,424 shares were traded during trading, a decline of 72% from the average session volume of 1,499,807 shares. The stock had previously closed at $5.73. Analyst Ratings Changes A […] ....

Piper Sandler , Voloridge Investment Management , News Ratings For Amneal Pharmaceuticals Daily , Barclays Plc , Group Plc , Institutional Investors Weigh In On Amneal Pharmaceuticals , Goldman Sachs Group , Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile , Pricet Rowe Associates Inc , Amneal Pharmaceuticals Price Performance , Vanguard Group Inc , Get Free Report , General Group Plc , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Strong Trading Volume

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 454,208 shares traded hands during mid-day trading, a decline of 69% from the previous session’s volume of 1,481,910 shares.The stock last traded at $5.96 and had previously closed at $5.81. Wall Street Analyst Weigh In Several research analysts recently […] ....

Hong Kong , United States , Piper Sandler , American Century Companies Inc , Y Intercept Hong Kong Ltd , Amneal Pharmaceuticals Price Performance , Tower Research Capital , Amneal Pharmaceuticals Inc , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Company Profile , Pricet Rowe Associates Inc , Amneal Pharmaceuticals , Goldman Sachs Group , Institutional Investors Weigh In On Amneal Pharmaceuticals , Get Free Report , Century Companies , Gate Manager , Research Capital , Amneal Pharmaceuticals Daily ,